Precision Medicine

Company will use the $58 million round of financing to advance its cloud-based platform for genomics and biomedical datasets.

Health systems, researchers, startups, app developers and EHR makers are all taking critical roles in growing the promise of precision medicine.

Michael Draugelis says artificial intelligence has big potential to drive analytics on varied and voluminous clinical data – but care must be taken to enable consistent and repeatable performance.

The hospital tapped FHIR-based alerts to deliver recommendations about genomics and genetic testing without bogging down doctors with too many extra clicks.

Siemens Healthineers bought Fast Track Diagnostics to build out its precision medicine technologies. Adding Fast Track Diagnostics molecular-testing technologies enables hospitals to target conditions such as respiratory infections, gastroenteritis, meningitis, hepatitis, infections of the immunosuppressed, tropical diseases, sexually transmitted diseases, and early childhood diseases. [Also: Precision med is about to have its breakout moment ] The tests can detect more than 140 viruses, bacteria, parasites, and fungi. Siemens Healthineers head of Molecular Diagnostics Fernando Beils said that the acquisition expands its precision medicine portfolio, while Fast Track Diagnostics CEO Bill Carman added that combining the technologies can help customers improve outcomes for patients. Fast Track has about 80 employees in Luxembourg, Malta and India. Siemens did not disclose terms of the acquisition. Twitter: @Bernie_HITN Email the writer: bernie.monegain@himssmedia.com

Genomic-informed therapy recommendations are becoming available for clinical decision support at the point of care.

HIMSS Analytics survey indicates focus on Infrastructure, funding and human capital.

Chief executive shares his vision for the future of genomics and offers a glimpse of the AI-based EHR the company is exploring.

2bPrecise announced a new pharmacogenomics system as more and more vendors bring tools to market to bring precision medicine to physicians at the point of care.

HIMSS survey reveals budget, data integration, lack of clinical expertise are concerns.